Ind-Swift Labs to sell API and CRAMS business to Synthimed for Rs 1,650cr

In a groundbreaking move that has left the pharmaceutical sector buzzing, the Board of Directors of Ind-Swift Laboratories Limited ("Ind-Swift") announced the blockbuster sale of ... Read More